Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
RNA polymerase I
transcription apparatus acquires and integrates the combined information from multiple cellular signalling cascades to regulate ribosome production essential for cell growth and proliferation. In the present study, we show that a subpopulation of
A-kinase anchoring protein 95
(
AKAP95
) targets the nucleolus during interphase and is involved in regulating rRNA production. We show that
AKAP95
co-localizes with the nucleolar upstream binding factor, an essential rRNA transcription factor. Similar to other members of the C2 H2 -zinc finger family, we show, using systematic selection and evolution of ligands by exponential enrichment and in vitro binding analysis, that
AKAP95
has a preference for GC-rich DNA in vitro, whereas fluorescence recovery after photobleaching analysis reveals
AKAP95
to be a highly mobile protein that exhibits
RNA polymerase I
and II dependent nucleolar trafficking. In line with its GC-binding features, chromatin immunoprecipitation analysis revealed
AKAP95
to be associated with ribosomal chromatin in vivo. Manipulation of
AKAP95
-expression in U2OS cells revealed a reciprocal relationship between the expression of
AKAP95
and 47S rRNA. Taken together, our data indicate that
AKAP95
is a novel nucleolus-associated protein with a regulatory role on rRNA production.
...
PMID:A-kinase anchoring protein AKAP95 is a novel regulator of ribosomal RNA synthesis. 2668 27